Target intelligence / Profile preview

Liver Tumor Vasculature (N/A)

Target
N/A
Molecular classification
Vascular Network, Tumor Microenvironment Component
01

Overview

Liver tumor vasculature refers to the network of blood vessels that supply nutrients and oxygen to liver tumors. This network is crucial for tumor growth, progression, invasion, and metastasis. It is characterized by aberrant angiogenesis, driven primarily by the VEGF/VEGFR and Angiopoietin/Tie pathways. Targeting this vasculature is a major therapeutic approach in liver cancer.

Other names
Hepatic Tumor VasculatureLiver Tumor AngiogenesisTumor-Associated Vasculature (Liver)
02

Mechanism of action

Anti-angiogenic therapies inhibit the formation of new blood vessels, thereby starving the tumor of nutrients and oxygen. Nanoparticle-based delivery enhances drug accumulation at the tumor site while minimizing systemic toxicity.

03

Biological functions

Nutrient Supply to TumorsOxygen Delivery to TumorsTumor Growth and ProgressionMetastasisImmune Cell Infiltration Modulation
04

Disease associations

CancerHepatocellular Carcinoma (HCC)Cavernous HemangiomaEpithelioid HemangioendotheliomaHepatic Angiosarcoma
05

Safety considerations

HypertensionThromboembolic eventsWound healing complicationsHemorrhage
06

Interacting drugs

Anti-VEGF therapies (e.g., Bevacizumab)

1 more in the full profile.

07

Biomarkers

VEGF plasma levelsAngiopoietin-2 plasma levelsMicrovessel Density (MVD) in HCC tissue

Beyond the preview

Go deeper on Liver Tumor Vasculature (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liver Tumor Vasculature (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call